Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

BiotTech Rises with the Index Tide

avatar
Kevin Travers wrote a column · Jan 22 23:51
After two major indexes reached all-time highs, pharmaceutical stocks for companies in drug trials were caught up in the energy and rocketed forward. The largest gainers were $Spyre Therapeutics (SYRE.US)$, up 26% Monday morning, and $Gyre Therapeutics (GYRE.US)$ +10%.
Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel. $Ginkgo Bioworks (DNA.US)$ also roase 9%, despite a new sell rating from Goldman Sachs.
But monday morning was not all roses for the biotech sector. Gilead Sciences fell 9% after a phase three lung cancer treatment trial failed to meet goals. ZLAB Zai Lab fell 7%
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
4
+0
1
Translate
Report
79K Views
Comment
Sign in to post a comment